Követés
Yogesh Kumar
Yogesh Kumar
Assistant Professor, Centre of Biomedical Research, SGPGIMS campus. Lucknow
E-mail megerősítve itt: cbmr.res.in - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Y Kumar, H Singh, CN Patel
Journal of infection and public health 13 (9), 1210-1223, 2020
2372020
Application of omics technologies for microbial community structure and function analysis in contaminated environment
V Kumar, K Singh, MP Shah, AK Singh, A Kumar, Y Kumar
Wastewater treatment, 1-40, 2021
1042021
AromaDb: a database of medicinal and aromatic plant’s aroma molecules with phytochemistry and therapeutic potentials
Y Kumar, O Prakash, H Tripathi, S Tandon, MM Gupta, LU Rahman, ...
Frontiers in plant science 9, 1081, 2018
752018
Short-term dietary changes can result in mucosal and systemic immune depression
F Siracusa, N Schaltenberg, Y Kumar, TR Lesker, B Steglich, T Liwinski, ...
Nature Immunology, 1-14, 2023
342023
Genome-wide detection of terpene synthase genes in holy basil (Ocimum sanctum L.)
Y Kumar, F Khan, S Rastogi, AK Shasany
PLoS One 13 (11), e0207097, 2018
322018
In vitro antimalarial activity and molecular modeling studies of novel artemisinin derivatives
R Gaur, HS Cheema, Y Kumar, SP Singh, DK Yadav, MP Darokar, F Khan, ...
RSC advances 5 (59), 47959-47974, 2015
322015
Antimalarial activity and safety assessment of Flueggea virosa leaves and its major constituent with special emphasis on their mode of action
SV Singh, A Manhas, Y Kumar, S Mishra, K Shanker, F Khan, ...
Biomedicine & Pharmacotherapy 89, 761-771, 2017
282017
Bioinformatics and computational tools in bioremediation and biodegradation of environmental pollutants
P Kumari, Y Kumar
Bioremediation for environmental sustainability, 421-444, 2021
272021
In silico identification and docking-based drug repurposing against the main protease of SARS-CoV-2, causative agent of COVID-19
Y Kumar, H Singh
242020
Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus
CN Patel, SP Jani, SP Kumar, KM Modi, Y Kumar
2022/12/1 151, 106318, 2022
202022
Design and synthesis of novel oleanolic acid based chromenes as anti-proliferative and anti-inflammatory agents
DS Raghuvanshi, N Verma, S Singh, S Luqman, AC Gupta, ...
New Journal of Chemistry 42 (20), 16782-16794, 2018
202018
Bivalent furostene carbamates as antiproliferative and antiinflammatory agents
N Pathak, K Fatima, S Singh, D Mishra, AC Gupta, Y Kumar, D Chanda, ...
The Journal of Steroid Biochemistry and Molecular Biology 194, 105457, 2019
162019
Silymarin, a polyphenolic flavonoid impede Plasmodium falciparum growth through interaction with heme
PR Mina, Y Kumar, AK Verma, F Khan, S Tandon, A Pal, MP Darokar
Natural Product Research 34 (18), 2647-2651, 2020
142020
Synthesis, molecular modelling studies of indolyl chalcone derivatives and their antimalarial activity evaluation
Jyoti, R Gaur, Y Kumar, HS Cheema, DS Kapkoti, MP Darokar, F Khan, ...
Natural Product Research 35 (19), 3261-3268, 2021
122021
Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition
AK Verma, K Fatima, RK Dudi, M Tabassum, H Iqbal, Y Kumar, S Luqman, ...
European Journal of Medicinal Chemistry 188, 111986, 2020
112020
Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH)
J Wagner, Y Kumar, A Lautenbach, P von Kroge, S Wolter, O Mann, ...
Lipids in Health and Disease 22 (1), 1, 2023
102023
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
AUK Nabeela Farhat, Divya Gupta, Abid Ali, Yogesh Kumar, Farheen Akhtar ...
Microbiol Spectr, 2022
82022
Synthesis and bioactivity evaluation of eugenol hybrids obtained by Mannich and 1, 3 dipolar cycloaddition reactions
K Buduma, N Kumar A, S Srinivas KVN, K Kumar J, S Chinde, AK Domatti, ...
Journal of Heterocyclic Chemistry 58 (11), 2078-2089, 2021
82021
Current potential therapeutic approaches against SARS-CoV-2: a review
DK Yadav, DD Singh, I Han, Y Kumar, EH Choi
Biomedicines 9 (11), 1620, 2021
72021
Comparative sequence analysis of SARS nCoV and SARS CoV genomes for variation in structural proteins
J Sangwan, S Tripathi, N Yadav, Y Kumar, N Sangwan
Proceedings of the Indian National Science Academy 89 (1), 60-76, 2023
42023
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20